Jim Simons acquired 42.8 Thousand Gain Therapeutics shares worth $137 Thousand. That's 0.00% of their equity portfolio (3013th largest holding). The first Gain Therapeutics trade was made in Q2 2022. Since then Jim Simons bought shares three more times and sold shares on three occasions. The investor's estimated purchase price is $162 Thousand, resulting in a loss of 16%.